Accelerating antiviral drug discovery: lessons from COVID-19

Accelerating antiviral drug discovery: lessons from COVID-19

During the coronavirus disease 2019 (COVID-19) pandemic, a wave of rapid and collaborative drug discovery efforts took place in academia and industry, culminating in several therapeutics being discovered, approved and deployed in a 2-year time frame. This article summarizes the collective experience...

Bibliografske podrobnosti
Main Authors:	von Delft, A, Hall, MD, Kwong, AD, Purcell, LA, Saikatendu, KS, Schmitz, U, Tallarico, JA, Lee, AA
Format:	Journal article
Jezik:	English
Izdano:	Springer Nature 2023

Podobne knjige/članki

Antiviral research : strategies in antiviral drug discovery /
od: LaFemina, Robert L., et al.
Izdano: (c200)

Successful strategies for the discovery of antiviral drugs /
od: Desai, Manoj C., et al.
Izdano: (2013)

Glycobiology against viruses: Antiviral drug discovery
od: Zitzmann, N, et al.
Izdano: (2006)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
od: Abdulaziz L, et al.
Izdano: (2022-03-01)

Antiviral drug discovery for emerging diseases and bioterrorism threats /
od: Torrence, Paul F.
Izdano: (2005)

Antiviral Drug Discovery for the Treatment of COVID-19 Infections
od: Teresa I. Ng, et al.
Izdano: (2022-05-01)

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
od: Kyeong-Ok Chang, et al.
Izdano: (2019-02-01)

Editorial of Special Column on Antiviral Drug Discovery and Pharmacology
od: Jun Wang, et al.
Izdano: (2022-04-01)

Antiviral drugs : from basic discovery through clinical trials /
od: Kazmierski, Wieslaw M.
Izdano: (c201)

Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
od: Shaoqing Du, et al.

Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
od: Xuan Xu, et al.
Izdano: (2021-10-01)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
od: Xinlei Li, et al.
Izdano: (2021-05-01)

MalDA, Accelerating Malaria Drug Discovery
od: Yang, Tuo, et al.
Izdano: (2021)

MalDA, Accelerating Malaria Drug Discovery
od: Yang, Tuo, et al.
Izdano: (2022)

Three Lessons from Accelerating Scientific Insight Discovery via Visual Querying
od: Doris Jung-Lin Lee, et al.
Izdano: (2020-10-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
od: Hatem A. Elshabrawy
Izdano: (2020-06-01)

Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
od: Toon Laeremans, et al.
Izdano: (2022-05-01)

Antiviral Agents: Discovery to Resistance
od: Catherine S. Adamson
Izdano: (2020-04-01)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
od: Xiaonan Liu, et al.
Izdano: (2021-10-01)

VDDB: A comprehensive resource and machine learning tool for antiviral drug discovery
od: Shunming Tao, et al.
Izdano: (2023-03-01)

Editor Profiles: Guest Editors of Special Column on Antiviral Drug Discovery and Pharmacology
Izdano: (2022-04-01)

Deep learning pipeline for accelerating virtual screening in drug discovery
od: Fatima Noor, et al.
Izdano: (2024-11-01)

An artificial intelligence accelerated virtual screening platform for drug discovery
od: Guangfeng Zhou, et al.
Izdano: (2024-09-01)

Advanced pathophysiology mimicking lung models for accelerated drug discovery
od: Thanh Huyen Phan, et al.
Izdano: (2023-04-01)

Perspective on the challenges and opportunities of accelerating drug discovery with artificial intelligence
od: John P. Santa Maria, et al.
Izdano: (2023-02-01)

An in vitro toolbox to accelerate anti-malarial drug discovery and development
od: Susan A. Charman, et al.
Izdano: (2020-01-01)

Discovery of Antivirals Using Phage Display
od: Esen Sokullu, et al.
Izdano: (2021-06-01)

An in-depth exploration of snake venom-derived molecules for drug discovery in advancing antiviral therapeutics
od: Hicham Hboub, et al.
Izdano: (2024-09-01)

Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses
od: Rafaela S. Fernandes, et al.
Izdano: (2020-05-01)

Editorial: Emerging and old viral diseases: Antiviral drug discovery from medicinal plants
od: Mohammed Rahmatullah, et al.
Izdano: (2022-08-01)

Genome-wide pan-GPCR cell libraries accelerate drug discovery
od: Hanting Yang, et al.
Izdano: (2024-10-01)

Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19
od: Indira Mikkili, et al.
Izdano: (2021-10-01)

Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery
od: Neil O Carragher, et al.
Izdano: (2011-04-01)

Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
od: Izumi V. Hinkson, et al.
Izdano: (2020-06-01)

Preparative Scale Resolution of Enantiomers Enables Accelerated Drug Discovery and Development
od: Hanna Leek, et al.
Izdano: (2017-01-01)

Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery
od: Lee R. Wright, et al.
Izdano: (2022-07-01)

Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases
od: Rima Hajjo, et al.
Izdano: (2023-02-01)

Antiviral Therapeutics Discovery for Enterovirus D68.
od: Prof Justin Jang H Chu
Izdano: (2025-03-01)

Milestones in the discovery of antiviral agents: nucleosides and nucleotides
od: Erik de Clercq
Izdano: (2012-12-01)

Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design
od: Ikuo Fujimori, et al.
Izdano: (2020-11-01)